Jefferies Group LLC Sorrento Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 14, 2021
SELL
$7.03 - $16.51 $351,500 - $825,500
-50,000 Closed
0 $0
Q4 2020

Sep 21, 2023
BUY
$5.76 - $11.95 $288,000 - $597,500
50,000 New
50,000 $341,000
Q4 2020

Feb 16, 2021
SELL
$5.76 - $11.95 $288,000 - $597,500
-50,000 Reduced 50.0%
50,000 $341,000
Q3 2020

Nov 13, 2020
BUY
$6.17 - $18.82 $617,000 - $1.88 Million
100,000 New
100,000 $1.12 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email